Your browser doesn't support javascript.
loading
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
Milo, Ron; Staun-Ram, Elsebeth; Karussis, Dimitrios; Karni, Arnon; Hellmann, Mark A; Bar-Haim, Erez; Miller, Ariel.
Afiliação
  • Milo R; Department of Neurology, Barzilai Medical Center, Ashkelon & Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Staun-Ram E; Multiple Sclerosis Center and Neuroimmunology Unit, Carmel Medical Center & Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Karussis D; Unit for Neuroimmunology, Multiple Sclerosis and Cell Therapy, Hadassah Medical Center & Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Karni A; Neuroimmunology and Multiple Sclerosis Unit, Tel Aviv Sourasky Medical Center & Sackler Faculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
  • Hellmann MA; Department of Neurology, Rabin Medical Center & Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bar-Haim E; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.
  • Miller A; Multiple Sclerosis Center and Neuroimmunology Unit, Carmel Medical Center & Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Front Immunol ; 13: 868915, 2022.
Article em En | MEDLINE | ID: mdl-35432335
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Clinical_trials / Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Clinical_trials / Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article